125 related articles for article (PubMed ID: 7629421)
1. DNA content in human colon cancer and non-neoplastic adjacent mucosa.
Saccani Jotti G; Fontanesi M; Orsi N; Sarli L; Pietra N; Peracchia A; Sansebastiano G; Becchi G
Int J Biol Markers; 1995; 10(1):11-6. PubMed ID: 7629421
[TBL] [Abstract][Full Text] [Related]
2. Analysis of subclonal expansion of colorectal carcinomas by flow cytometry.
Sugai T; Nakamura S; Habano W; Uesugi N; Sato H; Funato O; Sasou S; Orii S; Itoh C
Virchows Arch; 1999 May; 434(5):437-41. PubMed ID: 10389627
[TBL] [Abstract][Full Text] [Related]
3. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
[TBL] [Abstract][Full Text] [Related]
5. Abnormal DNA ploidy and proliferative patterns in superficial colonic epithelium adjacent to colorectal cancer.
Ngoi SS; Staiano-Coico L; Godwin TA; Wong RJ; DeCosse JJ
Cancer; 1990 Sep; 66(5):953-9. PubMed ID: 2386922
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in DNA diploid, aneuploid and multiploid colorectal carcinomas identified by the crypt isolation technique.
Sugai T; Habano W; Nakamura S; Sato H; Uesugi N; Takahashi H; Jiao Y; Yoshida T; Itoh C
Int J Cancer; 2000 Nov; 88(4):614-9. PubMed ID: 11058879
[TBL] [Abstract][Full Text] [Related]
7. Evolution of DNA ploidy state and DNA index in colorectal adenomas and carcinomas using the crypt isolation technique: new hypothesis in colorectal tumorigenesis.
Sugai T; Uesugi N; Nakamura S; Habano W; Jiao YF; Noro A; Takahashi H; Akasaka I; Higuchi T
Pathol Int; 2003 Mar; 53(3):154-62. PubMed ID: 12608896
[TBL] [Abstract][Full Text] [Related]
8. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival.
Enker WE; Kimmel M; Cibas ES; Cranor ML; Melamed MR
J Natl Cancer Inst; 1991 May; 83(10):701-7. PubMed ID: 2023271
[TBL] [Abstract][Full Text] [Related]
9. Aneuploidy characterizes adjacent non-malignant mucosa of ulcerative colitis-associated but not sporadic colorectal carcinomas: a matched-pair analysis.
Meyer KF; Nause SL; Freitag-Wolf S; Krüger S; Bruch HP; Roblick UJ; Habermann JK
Scand J Gastroenterol; 2013 Jun; 48(6):679-87. PubMed ID: 23544594
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
13. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy of colorectal carcinoma by tumour site, gender and history of noncolorectal malignancies.
Kouri M
Oncology; 1993; 50(1):41-5. PubMed ID: 8421597
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
16. Correlation between DNA content and p53 deletion in colorectal cancer.
Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
[TBL] [Abstract][Full Text] [Related]
17. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma.
Offerhaus GJ; De Feyter EP; Cornelisse CJ; Tersmette KW; Floyd J; Kern SE; Vogelstein B; Hamilton SR
Gastroenterology; 1992 May; 102(5):1612-9. PubMed ID: 1568571
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
[TBL] [Abstract][Full Text] [Related]
19. DNA flow cytometry of endoscopically examined colorectal adenocarcinomas.
Giaretti W; Sciallero S; Bruno S; Geido E; Aste H; Di Vinci A; d'Amore ES
Pathol Res Pract; 1989 Nov; 185(5):589-93. PubMed ID: 2626368
[TBL] [Abstract][Full Text] [Related]
20. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M
Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
